


The Chairman Hans Peter Bøhn has today, 14 December 2016, subscribed for 33.556
new shares in PCI Biotech Holding ASA (the "Company") at a subscription price of
NOK  7 per  share  by  exercising  33.556 subscription  rights  in the Company's
ongoing  rights issue. After the transaction, Hans  Peter Bøhn will have a total
shareholding  in the company  of 83.556 shares and  0 subscription rights in the
rights  issue. Hans Peter Bøhn has previously entered into a guarantee agreement
of  NOK  1 000 000 in  relation  to  the  rights  issue,  and todays exercise of
subscription rights will, in compliance with the guarantee agreement, reduce the
guarantee liability correspondingly.

Contact information:
PCI Biotech Holding ASA, Ullernchausséen 64, N-0379 Oslo
Ronny Skuggedal, CFO, rs@pcibiotech.no, Mobile: +47 9400 5757

This  information is subject to the  disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.


 
    